Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practicing in specific cardiology domains.
Coronary artery disease (CAD) undoubtedly remains the number one cause of death in the industrialised countries. In recent years, CMR trials, like MR-IMPACT, demonstrated an excellent diagnostic performance in detection of CAD. In addition, CMR techniques have been refined over the years to allow characterisation of cardiomyopathies and to improve the work-up of patients with chronic heart failure.
Anatomy and Right Planning - Ralf Wassmuth (Berlin,Germany)
LV Function, Mass and Post Processing - Jérome Garot (Massy, France)
CMR and Viability - A C Van Rossum (Amsterdam, Holland)
Flow Measurements - Hakan Arheden (Lund, Sweden)
Assessment of Ischemia by CMR - J Schwitter (Lausanne, Switzerland)
Dobutamine Stress CMR - Christophe Klein (Berlin, Germany)
Combined Stress (perfusion and functional reserve) - M Lombardi (Toscana, Italy)
Safety within the MIR environment - Roger Luechinger (Zurich, Switzerland)
CMR in Adult Congenital Heart Disease - Philip Kilner (London, UK)
How to plan CMR in adults with acquired heart disease - Steven Dymarkowski (Leuven, Belgium)
CMR Hypertrophic Cardiomyopathy - Rory O'Hanlan (London, UK)
CMR in Dilated Cardiomyopathy - A C Van Rossum (Amsetrdam, Holland)
ARVC - The Imager's view - Francisco Alpendurada (London, UK)
Myocardial Perfusion Imaging by CMR - Theodoros D Karamitsos (Oxford, UK)
Stress MRI technological improvement and clinical trials - Hassan Abdel Aty (Berlin, Germany)
MRI of the Coronary Arteries - Peter G Danias (Boston, USA)
T2 Imaging Techniques in Acute CAD - Anthony H Aletras (Maryland, USA)
Viability by MRI - The role of LGE - Christoph Klein (Berlin, Germany)
Viability - role of dobutamine CMR - Marco Gotte 5amsterdam, Netherlands)
EuroCMR Registry - Results of the German Pilot Phase
Myocarditis and Heart Failure - Pros and Cons to T2 Evaluation - Oliver Bruder (Essen, Germany)
How to fit CMR in the diagnostic pathway of Heart Failure and Myocarditis - Raad H Mohiaddin (London, UK)
MRI in complex congenital heart disease - Gigi P Festa (Pisa, Italy)
CMR in adult congenital heart disease - Sonya V Babu-Narayan (London, UK)
Using Hyperpolarised C labelled contrast media in studies of cardiac metabolism - Marie A Schroeder (Oxford, UK)
3D Cardiac Imaging - Is ready? Massimo Lombardi (Pisa, Italy)
MR Plaque imaging - anything new? Marc Sirol (Paris, France)
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved